Johnson & Johnson (JNJ) 108.31 $JNJ
Krispy Is Kremed; RIP Andy Grove; Biotechs in No-Man's Land: Jim Cramer's Best Blogs
at The Street - 2 hrs 59 mins ago
Cramer dissects Krispy Kreme, honors a tech pioneer and laments the state of biotech stocks.
BIIB: 254.69 (-0.55), VRX: 31.09 (-2.34), WMT: 68.00 (+0.54), INTC: 31.88 (-0.12), SHLD: 15.00 (+0.04), AGN: 279.32 (-1.99), SBUX: 58.36 (-0.47), JACK: 63.12 (+0.02), JNJ: 108.31 (-0.19), DNKN: 45.32 (-0.21), IBM: 147.95 (+2.55), CMG: 471.37 (-3.09), ABBV: 56.12 (-0.24), SNY: 38.87 (-0.53), KKD: 14.61 (+0.32), REGN: 370.80 (+5.42), HD: 130.46 (+0.24), PFE: 30.08 (-0.11), LLY: 71.12 (-0.05), GSK: 39.56 (+0.19), BMY: 62.52 (+0.18), PLKI: 51.07 (+0.98), DIN: 92.00 (-1.02), CELG: 100.54 (+0.62), QSR: 37.63 (-0.38), GILD: 91.32 (+1.24), MRK: 53.07 (-0.01), AZN: 28.00 (-0.01), MCD: 123.29 (-0.90), WEN: 10.42 (+0.06)
NY comptroller: 5 companies to disclose political spending
By MICHAEL VIRTANEN - AP - Fri Mar 25, 10:46AM CDT
ALBANY, N.Y. (AP) — Five more Fortune 500 companies have agreed to publicly report all direct and indirect political spending, according to New York's comptroller.
RAI: 49.70 (-0.58), NBL: 32.34 (-0.21), HOG: 47.86 (-0.51), KR: 37.65 (+0.06), PCG: 58.85 (-0.11), WU: 18.78 (-0.02), PCL: 36.54 (-1.53), CMCSK: 58.00 (-1.69), MAR: 68.64 (-0.96), SRE: 102.55 (+0.72), CSX: 26.17 (+0.31), AET: 112.41 (+0.66), LUV: 44.06 (-0.37), PEP: 100.68 (-0.13), JNJ: 108.31 (-0.19), VLO: 65.84 (+0.94), ESRX: 67.38 (+0.05), NI: 23.03 (+0.01), MRO: 10.29 (+0.10), X: 15.78 (+0.94), CMCSA: 60.01 (+0.76), UNP: 80.92 (-0.60), TRV: 115.39 (-0.50)
Global Lateral Flow Assay Market Value of USD 6.78 Billion by 2020 - Trends, Technologies & Opportunities Report 2015-2020 - Key Vendors: Danaher, Johnson & Johnson, Siemens
PR Newswire Europe - Fri Mar 25, 8:11AM CDT
DUBLIN, March 25, 2016 /PRNewswire/ --
JNJ: 108.31 (-0.19), DHR: 94.78 (-0.06)
10 High-Quality Dividend Growth Stocks Hedge Funds Love Right Now
at The Street - Thu Mar 24, 12:20PM CDT
Hedge funds and institutional investors have large holdings in these 10 must-see high-quality dividend growth stocks.
KO: 45.58 (+0.12), GD: 129.08 (-5.24), JNJ: 108.31 (-0.19), HD: 130.46 (+0.24), KMB: 133.55 (-0.43), WMT: 68.00 (+0.54), GIS: 61.36 (+0.35), WM: 59.11 (+0.20), CSCO: 27.96 (+0.13), PEP: 100.68 (-0.13)
Eli Lilly's Psoriasis Treatment, Taltz, Gains FDA Approval
Arpita Dutt - Zacks Investment Research - Thu Mar 24, 10:30AM CDT
Eli Lilly (LLY) intends to launch Taltz in the second quarter.
JNJ: 108.31 (-0.19), LLY: 71.12 (-0.05), NVS: 73.30 (-0.61)
The Zacks Analyst Blog Highlights: PowerShares S&P 500 High Dividend Low Volatility ETF, Guggenheim Defensive ETF, Tyson Foods and Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 8:30AM CDT
The Zacks Analyst Blog Highlights: PowerShares S&P 500 High Dividend Low Volatility ETF, Guggenheim Defensive ETF, Tyson Foods and Johnson & Johnson
JNJ: 108.31 (-0.19), DEF: 36.44 (-0.01), SPHD: 36.58 (+0.04), TSN: 66.89 (-0.55)
Branded Manufacturers Flock to Catalyst Americas 2016 for Influential E-Commerce Discussions
Business Wire - Thu Mar 24, 8:20AM CDT
ChannelAdvisor Corporation (NYSE:ECOM), a leading provider of cloud-based e-commerce solutions that enable retailers and branded manufacturers to increase global sales, today announced that top branded manufacturers like Deckers, Hoover, Johnson & Johnson, Samsung and Whirlpool EMEA are attending Catalyst Americas 2016 and participating in the conference's Brands track. Catalyst, taking place April 11-13 at the Aria Resort & Casino in Las Vegas, is the go-to event for brands and retailers to connect with peers and hear powerful keynotes from some of the top influencers and visionaries in e-commerce.
WHR: 175.09 (+0.08), JNJ: 108.31 (-0.19), ECOM: 10.48 (+0.06)
Portola Pharmaceuticals' Betrixaban Misses Mark, But All Is Not Lost
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 24, 8:14AM CDT
SOURCE: PORTOLA PHARMACEUTICALS Portola Pharmaceuticals ' 7,513 person head to head study evaluating its next-generation anticoagulant betrixaban against standard of care Lovenox in the prevention of blood clots missed its endpoint in one trial...
JNJ: 108.31 (-0.19), PTLA: 20.27 (-8.35), PFE: 30.08 (-0.11), BMY: 62.52 (+0.18), SNY: 38.87 (-0.53)
Attention Celgene Investors: New Competition Is on the Horizon
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 24, 8:02AM CDT
Image source: Pixabay. Shareholders of drug giant Celgene have very little to complain about, even if shares are off 13% on a trailing 12-month basis. If we back out our perspective a bit, Celgene shares are up more than 250% over the trialing...
JNJ: 108.31 (-0.19), CELG: 100.54 (+0.62)
AARP, Johnson & Johnson Health and Wellness Solutions, mPulse Mobile, Qualcomm Life, and Samsung to Participate at Connected Health Summit: Engaging Consumers
Marketwired - Thu Mar 24, 8:01AM CDT
Parks Associates announced that the third-annual Connected Health Summit: Engaging Consumers will be held August 30 - September 1, 2016, at the Omni Hotel San Diego, with executives from AARP, Johnson & Johnson Health and Wellness Solutions, mPulse Mobile, Qualcomm Life, and Samsung participating on this year's advisory board.
JNJ: 108.31 (-0.19)
Defensive Stocks & ETFs for Portfolio Protection
Neena Mishra - Zacks Investment Research - Wed Mar 23, 4:16PM CDT
Defensive stocks outperform during periods of low growth and high uncertainty.
JNJ: 108.31 (-0.19), DEF: 36.44 (-0.01), SPHD: 36.58 (+0.04), TSN: 66.89 (-0.55)
J&J, Roche Tie Up to Study Dual Immunotherapy Combination
Zacks Equity Research - Zacks Investment Research - Wed Mar 23, 3:40PM CDT
Johnson & Johnson (JNJ) inks a clinical trial deal with Roche (RHHBY) to assess dual monoclonal antibody combination therapy.
JNJ: 108.31 (-0.19), AMGN: 149.24 (+0.48)
Global Cosmeceuticals Market Worth USD 61 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Avon, Bayer, Johnson & Johnson - Research and Markets
Business Wire - Wed Mar 23, 2:04PM CDT
Research and Markets (http://www.researchandmarkets.com/research/246mph/global) has announced the addition of the "Global Cosmeceuticals Market Outlook 2020" report to their offering.
JNJ: 108.31 (-0.19)
Johnson & Johnson Is Headed for New All-Time Highs
at The Street - Wed Mar 23, 1:40PM CDT
Johnson & Johnson's rally ends a three-week consolidation, a very positive sign for investors.
JNJ: 108.31 (-0.19)
Johnson & Johnson Set to Possibly Pullback After Yesterday's Rally of 1.15%
Comtex SmarTrend(R) - Wed Mar 23, 12:17PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $107.20 to a high of $108.62. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $107.84 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JNJ: 108.31 (-0.19)
SmarTrend Watching for Potential Pullback in Shares of Johnson & Johnson After 1.15% Gain
Comtex SmarTrend(R) - Wed Mar 23, 12:16PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $107.20 to a high of $108.62. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $107.84 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JNJ: 108.31 (-0.19)
Novartis Stock Downgraded: 3 Things You Need to Know
Rich Smith, The Motley Fool - Motley Fool - Wed Mar 23, 12:00PM CDT
With its stock down 26% in 52 weeks, German pharmaceutical giant Novartis is looking cheap and winning fans on Wall Street. But Leerink Partners is not one of them. According to data from S&P Global Market Intelligence , 16 out of 34...
JNJ: 108.31 (-0.19), PFE: 30.08 (-0.11), NVS: 73.30 (-0.61)
Johnson & Johnson 7 Minute Wellness for Expecting and New Moms(TM) App Now Available for Apple and Android Devices
PR Newswire - Wed Mar 23, 9:00AM CDT
Johnson & Johnson Health and Wellness Solutions, Inc. today announced the launch of the Johnson & Johnson 7 Minute Wellness for Expecting and New Moms(TM) app, available on the App Store and the Google Play store. The 7 Minute Wellness for Expecting and New Moms(TM) app, is a simple, free, science-based wellness app designed to help expecting and new moms care for body, mind, and baby.
JNJ: 108.31 (-0.19)
Krispy Is Kremed; RIP Andy Grove; Biotechs in No-Man's Land: Jim Cramer's Best Blogs
at The Street - 2 hrs 59 mins ago
Cramer dissects Krispy Kreme, honors a tech pioneer and laments the state of biotech stocks.
BIIB: 254.69 (-0.55), VRX: 31.09 (-2.34), WMT: 68.00 (+0.54), INTC: 31.88 (-0.12), SHLD: 15.00 (+0.04), AGN: 279.32 (-1.99), SBUX: 58.36 (-0.47), JACK: 63.12 (+0.02), JNJ: 108.31 (-0.19), DNKN: 45.32 (-0.21), IBM: 147.95 (+2.55), CMG: 471.37 (-3.09), ABBV: 56.12 (-0.24), SNY: 38.87 (-0.53), KKD: 14.61 (+0.32), REGN: 370.80 (+5.42), HD: 130.46 (+0.24), PFE: 30.08 (-0.11), LLY: 71.12 (-0.05), GSK: 39.56 (+0.19), BMY: 62.52 (+0.18), PLKI: 51.07 (+0.98), DIN: 92.00 (-1.02), CELG: 100.54 (+0.62), QSR: 37.63 (-0.38), GILD: 91.32 (+1.24), MRK: 53.07 (-0.01), AZN: 28.00 (-0.01), MCD: 123.29 (-0.90), WEN: 10.42 (+0.06)
NY comptroller: 5 companies to disclose political spending
By MICHAEL VIRTANEN - AP - Fri Mar 25, 10:46AM CDT
ALBANY, N.Y. (AP) — Five more Fortune 500 companies have agreed to publicly report all direct and indirect political spending, according to New York's comptroller.
RAI: 49.70 (-0.58), NBL: 32.34 (-0.21), HOG: 47.86 (-0.51), KR: 37.65 (+0.06), PCG: 58.85 (-0.11), WU: 18.78 (-0.02), PCL: 36.54 (-1.53), CMCSK: 58.00 (-1.69), MAR: 68.64 (-0.96), SRE: 102.55 (+0.72), CSX: 26.17 (+0.31), AET: 112.41 (+0.66), LUV: 44.06 (-0.37), PEP: 100.68 (-0.13), JNJ: 108.31 (-0.19), VLO: 65.84 (+0.94), ESRX: 67.38 (+0.05), NI: 23.03 (+0.01), MRO: 10.29 (+0.10), X: 15.78 (+0.94), CMCSA: 60.01 (+0.76), UNP: 80.92 (-0.60), TRV: 115.39 (-0.50)
Global Lateral Flow Assay Market Value of USD 6.78 Billion by 2020 - Trends, Technologies & Opportunities Report 2015-2020 - Key Vendors: Danaher, Johnson & Johnson, Siemens
PR Newswire Europe - Fri Mar 25, 8:11AM CDT
DUBLIN, March 25, 2016 /PRNewswire/ --
JNJ: 108.31 (-0.19), DHR: 94.78 (-0.06)
10 High-Quality Dividend Growth Stocks Hedge Funds Love Right Now
at The Street - Thu Mar 24, 12:20PM CDT
Hedge funds and institutional investors have large holdings in these 10 must-see high-quality dividend growth stocks.
KO: 45.58 (+0.12), GD: 129.08 (-5.24), JNJ: 108.31 (-0.19), HD: 130.46 (+0.24), KMB: 133.55 (-0.43), WMT: 68.00 (+0.54), GIS: 61.36 (+0.35), WM: 59.11 (+0.20), CSCO: 27.96 (+0.13), PEP: 100.68 (-0.13)
Eli Lilly's Psoriasis Treatment, Taltz, Gains FDA Approval
Arpita Dutt - Zacks Investment Research - Thu Mar 24, 10:30AM CDT
Eli Lilly (LLY) intends to launch Taltz in the second quarter.
JNJ: 108.31 (-0.19), LLY: 71.12 (-0.05), NVS: 73.30 (-0.61)
The Zacks Analyst Blog Highlights: PowerShares S&P 500 High Dividend Low Volatility ETF, Guggenheim Defensive ETF, Tyson Foods and Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 8:30AM CDT
The Zacks Analyst Blog Highlights: PowerShares S&P 500 High Dividend Low Volatility ETF, Guggenheim Defensive ETF, Tyson Foods and Johnson & Johnson
JNJ: 108.31 (-0.19), DEF: 36.44 (-0.01), SPHD: 36.58 (+0.04), TSN: 66.89 (-0.55)
Branded Manufacturers Flock to Catalyst Americas 2016 for Influential E-Commerce Discussions
Business Wire - Thu Mar 24, 8:20AM CDT
ChannelAdvisor Corporation (NYSE:ECOM), a leading provider of cloud-based e-commerce solutions that enable retailers and branded manufacturers to increase global sales, today announced that top branded manufacturers like Deckers, Hoover, Johnson & Johnson, Samsung and Whirlpool EMEA are attending Catalyst Americas 2016 and participating in the conference's Brands track. Catalyst, taking place April 11-13 at the Aria Resort & Casino in Las Vegas, is the go-to event for brands and retailers to connect with peers and hear powerful keynotes from some of the top influencers and visionaries in e-commerce.
WHR: 175.09 (+0.08), JNJ: 108.31 (-0.19), ECOM: 10.48 (+0.06)
Portola Pharmaceuticals' Betrixaban Misses Mark, But All Is Not Lost
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 24, 8:14AM CDT
SOURCE: PORTOLA PHARMACEUTICALS Portola Pharmaceuticals ' 7,513 person head to head study evaluating its next-generation anticoagulant betrixaban against standard of care Lovenox in the prevention of blood clots missed its endpoint in one trial...
JNJ: 108.31 (-0.19), PTLA: 20.27 (-8.35), PFE: 30.08 (-0.11), BMY: 62.52 (+0.18), SNY: 38.87 (-0.53)
Attention Celgene Investors: New Competition Is on the Horizon
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 24, 8:02AM CDT
Image source: Pixabay. Shareholders of drug giant Celgene have very little to complain about, even if shares are off 13% on a trailing 12-month basis. If we back out our perspective a bit, Celgene shares are up more than 250% over the trialing...
JNJ: 108.31 (-0.19), CELG: 100.54 (+0.62)
AARP, Johnson & Johnson Health and Wellness Solutions, mPulse Mobile, Qualcomm Life, and Samsung to Participate at Connected Health Summit: Engaging Consumers
Marketwired - Thu Mar 24, 8:01AM CDT
Parks Associates announced that the third-annual Connected Health Summit: Engaging Consumers will be held August 30 - September 1, 2016, at the Omni Hotel San Diego, with executives from AARP, Johnson & Johnson Health and Wellness Solutions, mPulse Mobile, Qualcomm Life, and Samsung participating on this year's advisory board.
JNJ: 108.31 (-0.19)
Defensive Stocks & ETFs for Portfolio Protection
Neena Mishra - Zacks Investment Research - Wed Mar 23, 4:16PM CDT
Defensive stocks outperform during periods of low growth and high uncertainty.
JNJ: 108.31 (-0.19), DEF: 36.44 (-0.01), SPHD: 36.58 (+0.04), TSN: 66.89 (-0.55)
J&J, Roche Tie Up to Study Dual Immunotherapy Combination
Zacks Equity Research - Zacks Investment Research - Wed Mar 23, 3:40PM CDT
Johnson & Johnson (JNJ) inks a clinical trial deal with Roche (RHHBY) to assess dual monoclonal antibody combination therapy.
JNJ: 108.31 (-0.19), AMGN: 149.24 (+0.48)
Global Cosmeceuticals Market Worth USD 61 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Avon, Bayer, Johnson & Johnson - Research and Markets
Business Wire - Wed Mar 23, 2:04PM CDT
Research and Markets (http://www.researchandmarkets.com/research/246mph/global) has announced the addition of the "Global Cosmeceuticals Market Outlook 2020" report to their offering.
JNJ: 108.31 (-0.19)
Johnson & Johnson Is Headed for New All-Time Highs
at The Street - Wed Mar 23, 1:40PM CDT
Johnson & Johnson's rally ends a three-week consolidation, a very positive sign for investors.
JNJ: 108.31 (-0.19)
Johnson & Johnson Set to Possibly Pullback After Yesterday's Rally of 1.15%
Comtex SmarTrend(R) - Wed Mar 23, 12:17PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $107.20 to a high of $108.62. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $107.84 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JNJ: 108.31 (-0.19)
SmarTrend Watching for Potential Pullback in Shares of Johnson & Johnson After 1.15% Gain
Comtex SmarTrend(R) - Wed Mar 23, 12:16PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $107.20 to a high of $108.62. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $107.84 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JNJ: 108.31 (-0.19)
Novartis Stock Downgraded: 3 Things You Need to Know
Rich Smith, The Motley Fool - Motley Fool - Wed Mar 23, 12:00PM CDT
With its stock down 26% in 52 weeks, German pharmaceutical giant Novartis is looking cheap and winning fans on Wall Street. But Leerink Partners is not one of them. According to data from S&P Global Market Intelligence , 16 out of 34...
JNJ: 108.31 (-0.19), PFE: 30.08 (-0.11), NVS: 73.30 (-0.61)
Johnson & Johnson 7 Minute Wellness for Expecting and New Moms(TM) App Now Available for Apple and Android Devices
PR Newswire - Wed Mar 23, 9:00AM CDT
Johnson & Johnson Health and Wellness Solutions, Inc. today announced the launch of the Johnson & Johnson 7 Minute Wellness for Expecting and New Moms(TM) app, available on the App Store and the Google Play store. The 7 Minute Wellness for Expecting and New Moms(TM) app, is a simple, free, science-based wellness app designed to help expecting and new moms care for body, mind, and baby.
JNJ: 108.31 (-0.19)
